X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3210) 3210
Publication (382) 382
Newsletter (216) 216
Book Chapter (16) 16
Book Review (13) 13
Dissertation (10) 10
Conference Proceeding (7) 7
Newspaper Article (5) 5
Magazine Article (3) 3
Book / eBook (1) 1
Data Set (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fosfomycin (1718) 1718
humans (1302) 1302
fosfomycin - pharmacology (965) 965
index medicus (921) 921
anti-bacterial agents - pharmacology (765) 765
microbiology (731) 731
fosfomycin - therapeutic use (584) 584
microbial sensitivity tests (574) 574
pharmacology & pharmacy (570) 570
female (563) 563
male (527) 527
infectious diseases (511) 511
anti-bacterial agents - therapeutic use (452) 452
antibiotics (400) 400
fosfomycin - administration & dosage (385) 385
escherichia-coli (379) 379
animals (372) 372
research (351) 351
middle aged (350) 350
adult (341) 341
aged (285) 285
escherichia coli - drug effects (255) 255
urinary tract infections - drug therapy (246) 246
infections (240) 240
fosfomycin - analogs & derivatives (238) 238
urinary tract infections (232) 232
biochemical phenomena, metabolism, and nutrition (231) 231
escherichia coli (224) 224
bacteria (217) 217
drug resistance in microorganisms (215) 215
resistance (203) 203
biochemistry & molecular biology (190) 190
health aspects (187) 187
analysis (186) 186
drug resistance (182) 182
drug resistance, bacterial (179) 179
anti-bacterial agents - administration & dosage (178) 178
adolescent (177) 177
urinary tract infections - microbiology (168) 168
drug resistance, microbial (159) 159
fosfomycin - metabolism (152) 152
drug synergism (151) 151
susceptibility (150) 150
klebsiella-pneumoniae (147) 147
biosynthesis (143) 143
antimicrobial agents (140) 140
drug therapy, combination (140) 140
enterobacteriaceae (134) 134
urinary tract infection (134) 134
ciprofloxacin (132) 132
fosfomycin - pharmacokinetics (129) 129
nitrofurantoin (129) 129
enzymes (126) 126
escherichia coli - genetics (125) 125
pseudomonas aeruginosa - drug effects (125) 125
treatment outcome (124) 124
staphylococcus aureus - drug effects (122) 122
child (120) 120
time factors (119) 119
research article (118) 118
colistin (116) 116
epidemiology (114) 114
bacteria - drug effects (112) 112
infection (112) 112
genes (111) 111
vancomycin (111) 111
fosfomycin - chemistry (110) 110
prevalence (109) 109
staphylococcal infections - drug therapy (109) 109
antimicrobial resistance (108) 108
escherichia coli infections - drug therapy (108) 108
urinary-tract-infections (108) 108
drug resistance, multiple, bacterial (107) 107
e coli (105) 105
escherichia coli infections - microbiology (105) 105
kinetics (104) 104
isoprenoid biosynthesis (102) 102
molecular sequence data (102) 102
pharmacokinetics (102) 102
antibiotic resistance (101) 101
bacterial infections - drug therapy (100) 100
immunology (100) 100
physiological aspects (99) 99
escherichia coli - isolation & purification (98) 98
mutation (98) 98
fosfomycin - adverse effects (97) 97
identification (97) 97
fosfomycin resistance (96) 96
escherichia coli - enzymology (95) 95
multidrug-resistant (95) 95
pseudomonas aeruginosa (95) 95
care and treatment (94) 94
administration, oral (93) 93
pneumonia (92) 92
rats (92) 92
aged, 80 and over (91) 91
beta lactamases (91) 91
antibacterial agents (90) 90
dose-response relationship, drug (90) 90
tigecycline (90) 90
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2796) 2796
Japanese (205) 205
French (160) 160
Italian (90) 90
German (72) 72
Spanish (62) 62
Russian (24) 24
Chinese (19) 19
Turkish (14) 14
Portuguese (7) 7
Bulgarian (5) 5
Dutch (3) 3
Polish (3) 3
Croatian (2) 2
Hungarian (2) 2
Arabic (1) 1
Czech (1) 1
Danish (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2013, Volume 43, Issue 1, pp. 52 - 59
Abstract Fosfomycin is active in vitro against extensively drug-resistant (XDR) and pandrug-resistant (PDR) Pseudomonas aeruginosa and Klebsiella pneumoniae... 
Infectious Disease | Klebsiella | Pseudomonas | Critically ill | XDR | Fosfomycin | PDR | DEFINITION | MORTALITY | INFECTIOUS DISEASES | COMBINATION THERAPY | MICROBIOLOGY | INTRAVENOUS FOSFOMYCIN | K.-PNEUMONIAE | IMPACT | PREDICTORS | PHARMACOLOGY & PHARMACY | KLEBSIELLA-PNEUMONIAE | ENTEROBACTERIACEAE | Klebsiella pneumoniae - isolation & purification | Pseudomonas aeruginosa - isolation & purification | Klebsiella pneumoniae - drug effects | Prospective Studies | Humans | Middle Aged | Minocycline - analogs & derivatives | Critical Illness | Male | Bacterial Proteins - secretion | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - adverse effects | Minocycline - adverse effects | Minocycline - therapeutic use | Pseudomonas aeruginosa - enzymology | Drug Resistance, Multiple, Bacterial | Aged, 80 and over | Adult | Colistin - therapeutic use | Female | Anti-Bacterial Agents - adverse effects | Colistin - adverse effects | Intensive Care Units | Fosfomycin - therapeutic use | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Fosfomycin - adverse effects | Treatment Outcome | Klebsiella Infections - microbiology | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | beta-Lactamases - secretion | Administration, Intravenous | Drug Therapy, Combination - methods | Klebsiella pneumoniae - enzymology | Aged | Care and treatment | Pneumonia | Microbiology | Patient outcomes | Analysis | Bacterial pneumonia | Mortality | Bacteria | Drug resistance
Journal Article
Diagnostic Microbiology & Infectious Disease, ISSN 0732-8893, 10/2019, Volume 95, Issue 2, pp. 216 - 220
Intravenous fosfomycin is undergoing clinical development in the United States for treatment of complicated urinary tract infections (cUTIs) and may be... 
Carbapenemase | Synergy | Enterobacteriaceae | Fosfomycin
Journal Article
Journal Article
Emerging Infectious Diseases, ISSN 1080-6040, 09/2017, Volume 23, Issue 9, pp. 1564 - 1567
FosA, a glutathione S-transferase that inactivates fosfomycin, has been reported as the cause of enzymatic resistance to fosfomycin. We show that multiple... 
ANIMALS | INFECTIOUS DISEASES | FOSA3 | PREVALENCE | IMMUNOLOGY | Prevalence | Foscarnet - pharmacology | Escherichia coli - drug effects | Humans | Fosfomycin - metabolism | Microbial Sensitivity Tests | beta-Lactamases - genetics | Isoenzymes - metabolism | beta-Lactamases - metabolism | Escherichia coli Infections - drug therapy | France - epidemiology | Gene Expression | Escherichia coli - enzymology | Fosfomycin - pharmacology | Isoenzymes - genetics | Escherichia coli Infections - microbiology | Anti-Bacterial Agents - metabolism | Escherichia coli Proteins - metabolism | Plasmids - metabolism | Escherichia coli Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Plasmids - chemistry | Escherichia coli Proteins - genetics | Anti-Bacterial Agents - pharmacology | Drug Resistance, Multiple, Bacterial - drug effects | Drug resistance in microorganisms | Urinary tract infections | Beta lactamases | Glutathione transferase | Health aspects | Fosfomycin | bacteria | foodborne infections | Escherichia coli | fosA | Dispatch | acquired resistance | food safety | enteric infectious | Isolates, France | antimicrobial resistance | phosphonoformiate | ESBL | extended spectrum β-lactamase | France | Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among | fosfomycin
Journal Article
Journal of Aerosol Medicine and Pulmonary Drug Delivery, ISSN 1941-2711, 12/2014, Volume 27, Issue 6, pp. 441 - 448
Journal Article